Respiratory Device Market Forecast and Trends
Main powerful influences for
the worldwide respiratory care devices market are rise in the number of
long-lasting pulmonary obstructive diseased patients, and endless flow in
figures due to varying lifestyle and environment such as growing contamination
level and smokers, rising geriatric population, new launching of the product
joined with a solid pipeline of the product. In addition to that, the rise in
demand for home cares respiratory devices.
According to the Centers for
Disease Control and Prevention (CDC), more than 16 million population in
America were breathing with an illness caused by smoking such as lung diseases,
COPD, heart diseases, and cancer in 2014. Additionally, increasing the
geriatric population is the main cause of driving the market. However, the
absence of awareness in the emerging region, and some of the destructive
effects of respiratory devices on neonates can limit market growth.
Additionally, the excise tax on devices by some countries would imagine
affecting the market destructively.
Respiratory Device Market: Overview
Respiratory care devices are
the division of medical devices attentive to the dealing, management, control,
diagnostic assessment, and care of patients with irregularity in the
cardiopulmonary system. The methods are used in chronic obstructive pulmonary
diseases (COPD), deteriorating lung diseases, which mainly include chronic
bronchitis and emphysema. The market is observing decent development, as COPD
is one of the foremost causes of death worldwide.
Rise in the number of
long-lasting pulmonary obstructive diseased patients
The rise in the number of
patients due to varying lifestyles and environments such as growing contamination
level and smokers, rising geriatric population fuels the respiratory device
market. People are tending to junk food due to the increase in the number of
employed population because of this. They do not have time to cook the food by
the traditional method, which is foremost the respiratory problems among the
people. Growing the elderly population is the leading cause of driving the
market. However, the lack of awareness in the developing region, and some of
the critical effects of respiratory devices on neonates can bound the market
growth. Additionally, the excise tax on devices by some countries would imagine
affecting the market destructively.
Respiratory Device Market: Segmentation
Based on the product, the
market is divided into therapeutic devices, monitoring devices, diagnostic
devices, and consumables & accessories. The therapeutic devices segment
accounted for the major portion of the market in 2019. The huge share of this
segment is credited to the rising occurrence of chronic diseases and the
growing elderly population. The
respiratory care therapeutic devices market is additionally considered into
positive airway pressure (PAP) devices, ventilators, nebulizers, humidifiers,
oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery
units, and oxygen hoods. In 2018, the PAP devices section accounted for the
major portion of the respiratory care therapeutic devices market.
on indication Global respiratory device market is divided into Chronic
Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Infectious Disease,
Based on end-user, the
respiratory care devices market is divided into three main end-user
segments—hospitals, home care settings, and ambulatory upkeep centers. In 2019,
hospitals accounted for the major market part of the market, mostly because of
their financial capabilities, which allow them to purchase high-priced
instruments and the availability of trained professionals to function these
instruments, have safeguarded the high part of hospitals in this market.
Respiratory Device Market: Regional insights
Purely, the global
respiratory devices market has been divided into North America, Europe, Asia
Pacific, Latin America, and the Middle East and Africa. North America is likely
to dominate the global market throughout the projected period due to the
growing occurrence of respiratory disease. The fast acceptance of numerous
respiratory devices used for the treatment of chronic respiratory disease
dealing procedures will foster growth in North America.
The leading share of this
region can be endorsed to the sturdy existence of a large number of major
manufacturers of respiratory care devices, growing elderly population, high
prevalence of smoldering and respiratory diseases, and the occurrence of a
highly developed healthcare system. Moreover, the occurrence of advanced
healthcare infrastructure and high healthcare expenditure in North America is
also expected to drive the development of the market in this region.
objective of the Study:
To analyze and forecast the
global respiratory device market size of the market in terms of value.
To examine the careful
market segmentation and forecast the market size, in terms of value, based on
the region by segmenting.
The global respiratory
device market segmented into five regions, namely, North America, Europe, Asia
Pacific, Middle East, South America, and their leading countries.
To outline, categorized, and
forecast the global respiratory device market based on the Product Type,
Indication, End users and Regional.
To examine competitive
developments like Product Type, By Indication, End users, Region within the
global respiratory device market.
To highlight the impact
analysis of the factors affecting the market dynamics such as growth drivers.
To strategically profile the
key players and comprehensively analyze their market shares along with
detailing the competitive landscape for market leaders.
of the report
Historical Data –
Base Year – 2019
Revenue in USD
Germany,U.K,France,Italy ,Rest of Europe, China,India,Japan,South Korea,Rest of APAC, Brazil,Mexico,Argentina,Rest of Latin America,Saudi
Arabia,UAE,South Africa,Rest of MEA
By Product Type, By
Indication, By End Users and Region
Philips Healthcare, (Netherlands), Medtronic
plc (Ireland), and ResMed Inc. (US) dominated the global respiratory care
devices market in 2018. Other prominent players in the global market are
Masimo Corporation (US), Fisher & Paykel Healthcare Co. Ltd.
(NewZealand), Getinge AB (Sweden), Air Liquide (France), and Drägerwerk AG
& CO.KGAA (Germany). Other players in this market are Hamilton Medical AG
(Switzerland), Invacare Corporation (US), Vyaire Medical (US), Chart
Industries, Inc. (US), other prominent players.
By Product Type
Continuous Positive Airway Pressure (CPAP) Devices
Automatic PAP (APAP) Device
Bi-Level PAP (BPAP) Devices
High-end ICU Ventilators
Mid-end ICU ventilators
Basic ICU Ventilators
Fixed Oxygen Concentrators
Portable Oxygen Concentrators
Metered Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Nitric Oxide Delivery Units
Pulse oximeter sensors
Pulse Oximeter equipment
Peak Flow Meters
Other Diagnostic Devices
Nasal pillow masks
Chronic Obstructive Pulmonary Disease (COPD)
The other diseases
segment comprises lung cancer, tuberculosis, and idiopathic pulmonary fibrosis.
By End User
Home Care Settings
Ambulatory Care Centers
Middle East & Africa
Philips Healthcare (Netherlands),
Medtronic plc (Ireland),
ResMed Inc. (US)
Masimo Corporation (US)
Fisher & Paykel Healthcare Co. Ltd. (NewZealand)
Getinge AB (Sweden)
Air Liquide (France)
Drägerwerk AG & CO.KGAA (Germany)
Hamilton Medical AG (Switzerland)
Invacare Corporation (US)
Vyaire Medical (US)
Chart Industries, Inc. (US)
Other prominent players.
Philips unlocked its first Sleep and Respiratory Education
Center in Singapore in March 2018.
ResMed attained HB Healthcare Safety, a supplier of
home-based medical equipment for sleep and respiratory care devices in March
Business Questions Answer by the Report
How will the market drivers, restraints, and opportunities
affect the market dynamics?
What will be the market size in terms of value and volume and
market statistics with a detailed classification?
Which segment dominates the market or region, and one will be
the fastest - growing, and why?
A comprehensive survey of the competitive landscape and the
market participant players
Analysis of strategy adopted by the key player and their
impact on other players.
Customization Scope for the Client
Client satisfaction is our first and last priority, and that
is why BlueWeave Consulting offers customization according to Company’s
specific needs. The following customization options are available for the
Additional Company Information
With five additional company detail analysis
Additional country analysis
Detailed segment analysis